Welcome!

News Feed Item

Caribbean International Holdings (CIHN) Announces Change in Control; Seasoned Veteran in Stem Cell Industry Appointed as New CEO

Mark Farber MD, PhD, MS Received Degrees From Brown University and SUNY; During His Time at Harvard Medical School He Developed Bioreactor Designs for Stem Cell Based Tissue Engineered Heart Valves

SARASOTA, FL--(Marketwired - September 04, 2014) - Caribbean International Holdings (PINKSHEETS: CIHN) through its subsidiary, Regenerative BioScience, Inc. ("RBS"), announced today that on August 27, 2014, a private investment group, J3 Financial, has acquired a controlling interest in the Company. Former CEO and former controlling shareholder, Steven Swank has resigned as of that same date; and effective as of August 28, 2014, the Company has appointed Mark Farber MD, PhD, MS as the new CEO of CIHN.

A spokesperson for J3 stated that: "We had been tracking CIHN for some time and found its business model very attractive. We feel that this is a company that is ready to emerge and being able to acquire the talents and services of someone like Dr. Farber, will help us establish a sound foundation for future growth. We feel very lucky to have him onboard."

The Company also said that it intends to identify, recruit and hire additional industry professionals within the emerging stem cell industry as it builds the infrastructure to support a solid but steady growth. It will also be adding administrative and other veteran executives in key positions.

The Company spokesperson also said that the Company feels it is important in today's market to keep its shareholders fully abreast of ongoing events and or news and it plans on keeping the market up to date in order to remain fully transparent with the Company's current and/or potential future shareholders and the market at large. In that light, management of the Company will shortly be releasing a Shareholder Update and other pertinent information as it becomes available.

Below is a brief background and bio on the new CEO of CIHN, Mark Farber, MD, PhD, MS.

Dr. Mark Farber received his undergraduate degree in Chemical Engineering from Brown University in Providence, RI in 2001, followed by a Masters in Science in Engineering from Brown University in 2003. He received his MD/PhD combined degree from SUNY Downstate Medical Center in Brooklyn, NY in 2013. His PhD project titled "Simultaneous functional diffuse optical tomography and EEG in freely moving rats" involved developing an emerging non-invasive optical imaging technology to investigate brain blood flow in anesthetized, freely foraging, and sleeping rats. 

During the development of the diffuse optical tomography optical imager, Dr. Farber's research generated over $7 million in grants, including $130,000 from the competitive NIH Ruth Kirschstein National Research Service Award for MD/PhD students from the NIH/NINDS. The technology behind his PhD project for rat brain imaging was sold for over $750,000, and with the assistance of Dr. Farber his technology has been adapted for use in macaque research, clinical research, and the development of brain-machine interfaces.

Prior to completing his education in medicine and engineering, Dr. Farber spent three years working in developing stem cell bioreactors for use in research and tissue engineering. After completing his MS in Engineering, Dr. Farber briefly worked at ViaCell Inc. where he developed bioreactors to maximize stem cell yields from umbilical cord blood cultures. He then moved on to Harvard Medical School, where he worked in the Cardiovascular Pathology department and participated in research projects involving atherosclerosis, heart valve disease, embryology, and tissue engineering. During this time he initiated investigations into novel computerized methods of tissue collagen detection and quantification and developed bioreactor designs for stem cell based tissue engineered heart valves. 

Dr. Farber has also worked at top immunology, cancer, and chemical engineering labs in Brown University and National Institutes of Health during his undergraduate education. He was also a lecturer in anatomy and biostatistics at SUNY Downstate. Dr. Farber has over 17 years experience in laboratory-based science and engineering research.

About The Company:

Caribbean International Holdings, Inc. is a holding company for Regenerative Bio Science, Inc. ("RBSI"). The Company subsidiary RBSI is focused on helping individuals protect and ensure their future quality of life through Adult Stem Cell Incubation and the practice of regenerative medicine in the United States and the Dominican Republic. RBSI's mission is not only to allow patients to store their Stem Cells for future use, but also perform patient funded stem cell therapies from sports injuries to degenerative diseases such as MS, Arthritis, Degenerative Heart Diseases, Diabetes and a host of experimental therapies in the brain trauma disease sector including CTE. The goal is to become a global leader in establishing protocols that can be patented and utilized to heal patients around the world. 

Adult stem cells work as the repairmen of the body by replenishing and regenerating damaged tissues and cells. Certain conditions have shown marked improvement when treated with adult stem cells taken from the patient's own body. Regenerative BioScience is a revolution in healthcare using a patient's own adult stem cells.

For more information go to: http://www.regenerativebioscience.com/index.html.

Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available on at http://www.sec.gov.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Linux Academy, the foremost online Linux and cloud training platform and community, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Linux Academy was founded on the belief that providing high-quality, in-depth training should be available at an affordable price. Industry leaders in quality training, provided services, and student certification passes, its goal is to c...
With the proliferation of both SQL and NoSQL databases, organizations can now target specific fit-for-purpose database tools for their different application needs regarding scalability, ease of use, ACID support, etc. Platform as a Service offerings make this even easier now, enabling developers to roll out their own database infrastructure in minutes with minimal management overhead. However, this same amount of flexibility also comes with the challenges of picking the right tool, on the right ...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at 20th Cloud Expo, Ed Featherston, director/senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
910Telecom exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and exchanges.
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
China Unicom exhibit at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. China United Network Communications Group Co. Ltd ("China Unicom") was officially established in 2009 on the basis of the merger of former China Netcom and former China Unicom. China Unicom mainly operates a full range of telecommunications services including mobile broadband (GSM, WCDMA, LTE FDD, TD-LTE), fixed-line broadband, ICT, data communica...
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, will present an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He will expound on the industry issues he frequently came up against as an analyst, and...
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
"We're bringing out a new application monitoring system to the DevOps space. It manages large enterprise applications that are distributed throughout a node in many enterprises and we manage them as one collective," explained Kevin Barnes, President of eCube Systems, in this SYS-CON.tv interview at DevOps at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...